Annovis Bio, Inc. · NYSE:ANVS
Annovis Bio, Inc. shareholders
As of Jun 30, 2026, 59 institutions reported holding Annovis Bio, Inc., 25.5% of its shares. Largest: Empery Asset Management, LP, Marshall Wace, LLP and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Annovis Bio, Inc. | Change | Filed |
|---|---|---|---|---|
| Empery Asset Management, LP | 2.4M | 5.6% | new | Aug 11, 2026 |
| Marshall Wace, LLP | 1.84M | 4.3% | +655K | Aug 13, 2026 |
| Vanguard | 1.84M | 4.3% | +820K | Aug 13, 2026 |
| Tudor Investment Corp Et Al | 1.36M | 3.2% | new | Aug 14, 2026 |
| Renaissance Technologies | 1M | 2.4% | +655K | Aug 13, 2026 |
| Two Sigma | 580K | 1.4% | −48,088 | Aug 14, 2026 |
| Geode Capital | 284K | 0.67% | +36,304 | Aug 12, 2026 |
| BlackRock | 250K | 0.59% | +110K | Aug 7, 2026 |
| Citadel | 244K | 0.57% | new | Aug 14, 2026 |
| Susquehanna | 147K | 0.34% | −71,532 | Aug 14, 2026 |